Physician profile
Dennis Gage
NPI 1023014776
$5,179.49
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,391 · 2020: $767 · 2021: $20.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $612.28 | 2019-2020 | |
| Tosoh Bioscience, INC. | $557.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.51 | 2019-2020 | |
| Abbvie INC. | $462.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $432.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $414.47 | 2019-2020 | |
| Lilly USA, LLC | $365.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $267.71 | 2019-2020 | |
| Amgen INC. | $237.74 | 2019-2020 | |
| Antares Pharma, INC. | $143.57 | 2019-2020 | |
| Shire North American Group INC | $130.96 | 2019 | |
| Ibsa Pharma INC. | $128.53 | 2019 | |
| Mannkind Corporation | $117.91 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $113.37 | 2019-2020 | |
| Aytu Biopharma, INC. | $110.18 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $86.64 | 2019 | |
| Valeritas, INC. | $68.28 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $46.76 | 2019 | |
| Abbott Laboratories | $43.14 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.07 | 2019 | |
| Insulet Corporation | $39.88 | 2019 | |
| Companion Medical, INC. | $36.97 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $36.09 | 2019 | |
| Radius Health, INC. | $31.62 | 2019 | |
| Medtronic Minimed, INC. | $24.35 | 2020 | |
| Vivus LLC | $24.32 | 2019 | |
| Amarin Pharma, INC. | $24.01 | 2020 | |
| Opko Pharmaceuticals, LLC | $23.85 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $20.45 | 2019 | |
| Currax Pharmaceuticals LLC | $19.23 | 2019 | |
| Pfizer INC. | $16.48 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $3.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Gage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.